Chenyu Zhu

Chenyu Zhu

Auto-generated profile, based on publicly available information

Chenyu Zhu

Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
MQMengdi Qu
Mengdi Qu
CZChenyu Zhu
Chenyu Zhu
CSCaihong Sun
Caihong Sun
SZShuainan Zhu
Shuainan Zhu
HZHao Zhang
Hao Zhang
DZDi Zhou
Di Zhou
Background: Pancreatic cancer is very susceptible to metastasis with a high mortality. Neutrophil extracellular traps (NETs) have been reported to be associated with poor prognosis in patients suffering from pancreatic cancer. However, the underlying mechanisms by which NETs facilitate cancer progression remain poorly understood. Methods: The expression of NETs was assessed in pancreatic cancer tissues and plasma samples from patients. Neutrophils were isolated from the blood of individuals diagnosed with pancreatic cancer to evaluate NETs formation. The impact of NETs on the progression of pancreatic cancer cells was investigated, along with a series of experiments aimed at elucidating the interaction mechanisms between neutrophils and cancer cells. Results: Pancreatic cancer samples had higher levels of NETs, and NETs formation was intensified in neutrophils derived from patients. NETs significantly promoted both migration and invasion capabilities in pancreatic cancer cells. Furthermore, the stimulator of interferon genes (STING) signaling pathway was stimulated to produce interleukin‐8 (IL‐8), which subsequently recruited more neutrophils and mediated further formation of NETs. Conclusions: Our data indicate a NETs–cancer aggressive crosstalk in pancreatic cancer. Specifically, NETs stimulate tumor cells to secrete IL‐8, thereby promoting NETosis within the tumor microenvironment. Consequently, NETs may be a key target for pancreatic cancer treatment.